CN101068540B - 抗病毒性和免疫刺激性海鱼油组合物 - Google Patents

抗病毒性和免疫刺激性海鱼油组合物 Download PDF

Info

Publication number
CN101068540B
CN101068540B CN200580041636XA CN200580041636A CN101068540B CN 101068540 B CN101068540 B CN 101068540B CN 200580041636X A CN200580041636X A CN 200580041636XA CN 200580041636 A CN200580041636 A CN 200580041636A CN 101068540 B CN101068540 B CN 101068540B
Authority
CN
China
Prior art keywords
pharmaceutical composition
composition according
mass
polyunsaturated fatty
sin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200580041636XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101068540A (zh
Inventor
J·兹贝尔奇
A·杰德纳科威茨
E·康泰
G·奥本
K·毕罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinnex Mueszaki Fejlesztoe S T
Original Assignee
Sinnex Mueszaki Fejlesztoe S T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinnex Mueszaki Fejlesztoe S T filed Critical Sinnex Mueszaki Fejlesztoe S T
Publication of CN101068540A publication Critical patent/CN101068540A/zh
Application granted granted Critical
Publication of CN101068540B publication Critical patent/CN101068540B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200580041636XA 2004-12-03 2005-11-15 抗病毒性和免疫刺激性海鱼油组合物 Expired - Fee Related CN101068540B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0402490A HU227588B1 (hu) 2004-12-03 2004-12-03 Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
HUP0402490 2004-12-03
PCT/HU2005/000122 WO2006059169A2 (en) 2004-12-03 2005-11-15 Antiviral and immunostimulating marine fish oil composition

Publications (2)

Publication Number Publication Date
CN101068540A CN101068540A (zh) 2007-11-07
CN101068540B true CN101068540B (zh) 2013-01-09

Family

ID=89985663

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200580041636XA Expired - Fee Related CN101068540B (zh) 2004-12-03 2005-11-15 抗病毒性和免疫刺激性海鱼油组合物

Country Status (13)

Country Link
US (1) US9381213B2 (https=)
EP (1) EP1830861B1 (https=)
JP (1) JP4976307B2 (https=)
KR (1) KR101263963B1 (https=)
CN (1) CN101068540B (https=)
AT (1) ATE429236T1 (https=)
CA (1) CA2588195C (https=)
DE (1) DE602005014142D1 (https=)
DK (1) DK1830861T3 (https=)
ES (1) ES2326091T3 (https=)
HU (1) HU227588B1 (https=)
PL (1) PL1830861T3 (https=)
WO (1) WO2006059169A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1800675T3 (da) 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
SG10201605794PA (en) * 2009-04-29 2016-09-29 Amarin Pharmaceuticals Ie Ltd Stable Pharmaceutical Composition And Methods Of Using Same
JP5710150B2 (ja) * 2010-04-08 2015-04-30 持田製薬株式会社 潜伏性感染疾患の再発抑制剤
JP2012149000A (ja) * 2011-01-18 2012-08-09 Junsei Educational Institution 免疫賦活剤ならびにこれを含む食品および医薬組成物
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
US20220175850A1 (en) * 2019-04-01 2022-06-09 Houn Simon Hsia Compositions and methods for cancer therapy
AU2021324673B2 (en) * 2020-08-10 2025-07-24 Houn Simon Hsia Compositions and methods for treating viral infection

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907688A1 (de) * 1988-03-09 1989-09-21 Biorex Kft Salze von ungesaettigten fettsaeuren mit aminosaeuren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie die verwendung der ersteren
DE3907649A1 (de) * 1988-03-09 1989-09-28 Biorex Kft Arzneimittel, geeignet bei der bekaempfung von viren und der immunstimulierung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
EP0891771A1 (en) * 1997-07-08 1999-01-20 Health Now, Inc. Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases
WO1999029316A1 (en) * 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
AT412758B (de) * 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
ATE555782T1 (de) * 2002-03-08 2012-05-15 Philera New Zealand Ltd Prävention und/oder behandlung von kardiovaskulären erkrankungen und/oder damit zusammenhängender herzinsuffizienz

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907688A1 (de) * 1988-03-09 1989-09-21 Biorex Kft Salze von ungesaettigten fettsaeuren mit aminosaeuren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie die verwendung der ersteren
DE3907649A1 (de) * 1988-03-09 1989-09-28 Biorex Kft Arzneimittel, geeignet bei der bekaempfung von viren und der immunstimulierung

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
T Hamazaki, et al..intravenous infusion of n-3 polyunsaturated fatty acids.proceedings of the society for experimental biology and medicine200 2.1992,200(2),P.171-173.
T Hamazaki, et al..intravenous infusion of n-3 polyunsaturated fatty acids.proceedings of the society for experimental biology and medicine200 2.1992,200(2),P.171-173. *
戴聪杰.大竹蛏软体部分营养成分分析及其评价.集美大学学报7 4.2002,7(4),第304-308页.
戴聪杰.大竹蛏软体部分营养成分分析及其评价.集美大学学报7 4.2002,7(4),第304-308页. *
谢巧雄，等.中华倒刺鲃的人工驯化饲养试验.贵州农业科学31 4.2003,31(4),第41-43页.
谢巧雄,等.中华倒刺鲃的人工驯化饲养试验.贵州农业科学31 4.2003,31(4),第41-43页. *

Also Published As

Publication number Publication date
DK1830861T3 (da) 2009-07-27
JP4976307B2 (ja) 2012-07-18
PL1830861T3 (pl) 2009-09-30
KR101263963B1 (ko) 2013-05-13
HU0402490D0 (en) 2005-02-28
KR20070086689A (ko) 2007-08-27
EP1830861A2 (en) 2007-09-12
EP1830861B1 (en) 2009-04-22
CN101068540A (zh) 2007-11-07
ATE429236T1 (de) 2009-05-15
WO2006059169A3 (en) 2007-02-22
ES2326091T3 (es) 2009-09-30
US9381213B2 (en) 2016-07-05
HU227588B1 (hu) 2011-09-28
DE602005014142D1 (de) 2009-06-04
JP2008521877A (ja) 2008-06-26
HUP0402490A2 (en) 2009-04-28
CA2588195C (en) 2014-12-23
CA2588195A1 (en) 2006-06-08
US20080131519A1 (en) 2008-06-05
WO2006059169A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
US6255347B1 (en) Methods and compositions comprising R-ibuprofen
EP0346451A1 (en) Antiviral activity of fatty acids and monoglycerides
EP0465423A2 (en) Antimicrobial fatty compositions
JP4700808B2 (ja) フルボ酸、および種々の状態の処置におけるその使用
WO1997048391A9 (en) Methods and compositions comprising r-ibuprofen
FR2628324A1 (fr) Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer
CN101068540B (zh) 抗病毒性和免疫刺激性海鱼油组合物
JP7364560B2 (ja) 生殖補助医療用培地
US20230090982A1 (en) Drug for treating coronaviral and retroviral infections and hepatitis c
US5466714A (en) Spermicidal and cytocidal fatty acid compositions
Zahid et al. Effect of chloroquine on liver weight of developing albino rats
EP4398878A1 (en) A self-emulsifying drug delivery system (sedds) of punicic acid combined with neuroprotective natural products to delay onset, prevent, or reverse neurodegenerative disease
HK1113910A (en) Antiviral and immunostimulating marine fish oil composition
CA2404322A1 (en) Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
JP4417273B2 (ja) 精子活性化剤および精子不活性化剤
US20110105617A1 (en) Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof
JPH0748279A (ja) 後天性免疫不全症候群の治療法
US20080058422A1 (en) Antineoplastic Preparation and the Use of Antineoplastic Preparation
Audit et al. Possible involvement of an acylation mechanism in thalidomide‐induced teratogenesis of the newt (Pleurodeles waltl.)
RU2294645C2 (ru) Способ производства йодированных продуктов
James Observations related to the mechanisms of tetracycline-induced lipid accumulation in a strain of mouse fibroblasts cultivated in vitro
Cameron Mechanism of prolactin action on lipogenesis in mammary gland explants from midpregnant mice
HK1056116A1 (en) Sucrose ester c-20 to c-28 alcohol formulation
HK1056116B (en) Sucrose ester c-20 to c-28 alcohol formulation
LT5643B (lt) Sidabro/vandens, sidabro gelių ir sidabro pagrindo kompozicijos

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1113910

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1113910

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130109

Termination date: 20161115

CF01 Termination of patent right due to non-payment of annual fee